Human embryonic stem cells are capable of executing G1/S checkpoint activation

Stem Cells

Volumn 28, Issue 7, 2010, Pages 1143-1152

  Bárta, Tomáš ^a,b   Vinarský, Vladimír ^a,b   Holubcová, Zuzana ^a   Doležalová, Dáša ^a,b   Verner, Jan ^c   Pospíšilová, Šárka ^c   Dvořák, Petr ^a,b   Hampl, Aleš ^a,b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^c UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Cdc25A; Checkpoint activation; DNA damage; Human embryonic stem cells; p53; UVC

Indexed keywords

CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE 2; HISTONE H2AX; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA DAMAGE; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; ULTRAVIOLET C RADIATION;

CDC25 PHOSPHATASES; CELL DIFFERENTIATION; CELL LINE; CYCLIN-DEPENDENT KINASE 2; DNA DAMAGE; G1 PHASE; HUMANS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; S PHASE; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 77954831777     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.451     Document Type: Article

References (38)

1. Maitra A, Arking DE, Shivapurkar N et al. Genomic alterations in cultured human embryonic stem cells. Nat Genet 2005;37:1099-1103.
2. Baker DEC, Harrison NJ, Maltby E et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol 2007;25:207-215.
3. Gertow K, Cedervall J, Unger C et al. Trisomy 12 in HESC leads to no selective in vivo growth advantage in teratomas, but induces an increased abundance of renal development. J Cell Biochem 2007;100: 1518-1525. (Pubitemid 46515583)
4. Blum B, Bar-Nur O, Golan-Lev T et al. The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol 2009;27:281-287.
5. Bartek J, Lukas J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett 2001;490:117-122.
6. Mailand N, Falck J, Lukas C et al. Rapid destruction of human Cdc25A in response to DNA damage. Science 2000;288:1425-1429.
7. Ray D, Kiyokawa H. Cdc25A phosphatase: A rate-limiting oncogene that determines genomic stability. Cancer Res 2008;68:1251-1253.
8. Becker KA, Ghule PN, Therrien JA et al. Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J Cell Physiol 2006;209:883-893.
9. Becker KA, Stein JL, Lian JB et al. Establishment of histone gene regulation and cell cycle checkpoint control in human embryonic stem cells. J Cell Physiol 2007;210:517-526.
10. Filion TM, Qiao M, Ghule PN et al. Survival responses of human embryonic stem cells to DNA damage. J Cell Physiol 2009;220:586-592.
11. Adewumi O, Aflatoonian B, Ahrlund-Richter L et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007;25:803-816.
12. Paull TT, Rogakou EP, Yamazaki V et al. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 2000;10:886-895.
13. Morgan DO. Cyclin-dependent kinases: Engines, clocks, and micro-processors. Annu Rev Cell Dev Biol 1997;13:261-291.
14. Zhang X, Neganova I, Przyborski S et al. A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and Cdc25A. J Cell Biol 2009;184:67-82.
15. Goloudina A, Yamaguchi H, Chervyakova DB et al. Regulation of human Cdc25A stability by Serine 75 phosphorylation is not sufficient to activate a S phase checkpoint. Cell Cycle 2003;2:473-478.
16. Hong Y, Stambrook PJ. Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc Natl Acad Sci USA 2004;101:14443-14448.
17. Koledova Z, Kafkova LR, Krämer A et al. DNA Damage-induced degradation of Cdc25A does not lead to inhibition of Cdk2 activity in mouse embryonic stem cells. Stem Cells 2010;28:450-461.
18. Imreh MP, Gertow K, Cedervall J et al. In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells. J Cell Biochem 2006;99:508-516.
19. Catalina P, Montes R, Ligero G et al. Human ESCs predisposition to karyotypic instability: Is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties? Mol Cancer 2008;7:76-84.
20. Wu H, Kim KJ, Mehta K et al. Copy number variant analysis of human embryonic stem cells. Stem Cells 2008;26:1484-1489.
21. Nevins JR, Leone G, DeGregori J et al. Role of the Rb/E2F pathway in cell growth control. J Cell Physiol 1997;173:233-236.
22. Savatier P, Huang S, Szekely L et al. Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene 1994;9:809-818. (Pubitemid 24065919)
23. Stead E, White J, Faast R et al. Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 2002;21:8320-8333.
24. White J, Stead E, Faast R et al. Developmental activation of the Rb-E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation. Mol Biol Cell 2005;16:2018-2027.
25. Neganova I, Zhang X, Atkinson S et al. Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells. Oncogene 2009;28:20-30.
26. Becker KA, Ghule PN, Lian JB et al. Cyclin D2 and the CDK substrate p220(NPAT) are required for self-renewal of human embryonic stem cells. J Cell Physiol 2010;222:456-464.
27. Filipczyk AA, Laslett AL, Mummery C et al. Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells. Stem Cell Res 2007;1:45-60.
28. Sengupta S, Nie J, Wagner RJ et al. MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells. Stem Cells 2009; 27:1524-1528.
29. Qin H, Yu T, Qing T et al. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J Biol Chem 2007;282: 5842-5852. (Pubitemid 47093795)
30. Maimets T, Neganova I, Armstrong L et al. Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells. Oncogene 2008;27:5277-5287.
31. Momcilović O, Choi S, Varum S et al. Ionizing radiation induces ataxia telangiectasia mutated-dependent checkpoint signaling and G(2) but not G(1) cell cycle arrest in pluripotent human embryonic stem cells. Stem Cells 2009;27:1822-1835.
32. Aladjem MI, Spike BT, Rodewald LW et al. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol 1998;8:145-155.
33. Wang X, Lui VCH, Poon RTP et al. DNA damage mediated s and g(2) checkpoints in human embryonal carcinoma cells. Stem Cells 2009;27:568-576.
34. Kang T, Wei Y, Honaker Y et al. GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell 2008;13: 36-47.
35. Conklin JF, Sage J. Keeping an eye on retinoblastoma control of human embryonic stem cells. J Cell Biochem 2009;108:1023-1030.
36. Brons IGM, Smithers LE, Trotter MWB et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007;448: 191-195.
37. Tesar PJ, Chenoweth JG, Brook FA et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007;448:196-199.
38. Osafune K, Caron L, Borowiak M et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol 2008;26:313-315. (Pubitemid 351355125)